Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 21.09.2026 2 Acta Obstet Gynecol Scand 1 Acta Radiol 1 Adv Med Sci 1 Am J Obstet Gynecol 1 Appl Biochem Biotechnol 1 Biomed Rep 1 Biosci Rep 2 BMC Cancer 1 BMC Med Imaging 1 BMC Microbiol 1 BMC Pregnancy Childbirth 2 BMC Womens Health 1 BMJ Open 1 Brief Funct Genomics 1 Can Oncol Nurs J 1 Cancer Treat Res Commun 4 Cancers (Basel) 1 China CDC Wkly 2 Diagnostics (Basel) 2 Eur Radiol 1 F1000Res 1 Front Genet 1 Front Immunol 5 Front Oncol 1 Front Public Health 1 Genomics Proteomics Bioinformatics 2 Healthcare (Basel) 1 Int J Clin Oncol 1 Int J Hematol Oncol Stem Cell Res 2 Int J Mol Sci 1 J Adv Nurs 1 J Obstet Gynaecol Res 1 J Photochem Photobiol B 1 JCO Glob Oncol 3 Medicine (Baltimore) 1 Nat Biomed Eng 1 Naunyn Schmiedebergs Arch Pharmacol 1 Obstet Gynecol Int 1 Perm J 1 PLOS Glob Public Health 1 Public Health 1 Semin Ultrasound CT MR 1 Spectrochim Acta A Mol Biomol Spectrosc 1 Wiad Lek 2 Zhonghua Yu Fang Yi Xue Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. KATHOLM KK, Eriksen LK, Lycke KD, Larsen NL, et al
   Active surveillance of cervical intraepithelial neoplasia and adverse pregnancy outcomes: A register-based cohort study.
   Acta Obstet Gynecol Scand. 2026 Jul 1. doi: 10.1111/aogs.70304.
   PubMed         Abstract available
   
   
2. VAN DE KAM L, Siebers A, Bekkers R, van Hamont D, et al
   Loss to follow-up in patients diagnosed with or treated for low- and high-grade squamous intraepithelial lesions: A comparison of general practitioner- and gynecologist-led surveillance.
   Acta Obstet Gynecol Scand. 2026 Jul 21:10.1111/aogs.70301.
   PubMed         Abstract available
   
   

   
   Acta Radiol

3. ZEINALKHANI F, Kamali Hakim P, Sharifi A, Azizzadeh A, et al
   Age as a pre-operative predictor of uterine, bladder, and intestinal invasion in cervical cancer.
   Acta Radiol. 2026 Sep 16:2841851261486043. doi: 10.1177/02841851261486043.
   PubMed         Abstract available
   
   

   
   Adv Med Sci

4. PAUDEL P, Sah A
   Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: A systematic review and meta-analysis.
   Adv Med Sci. 2026 Sep 16:S1896-1126(26)00038-6. doi: 10.1016/j.advms.2026.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

5. LU TF, Shih YH, Lu CH
   Interpreting Long-Term Hormone Therapy Associations After Cervical Cancer Chemoradiotherapy (Reply to Letter-to-the-Editor).
   Am J Obstet Gynecol. 2026 Sep 18:S0002-9378(26)00490.
   PubMed        
   
   

   
   Appl Biochem Biotechnol

6. ZHANG M, Hai J, Yang J, Zhang Y, et al
   Nuclear Import of E2F1 Regulated by KPNB1 is Essential for Proliferation and Invasion of Cervical Cancer Cells.
   Appl Biochem Biotechnol. 2026 Sep 18. doi: 10.1007/s12010-026-05928.
   PubMed         Abstract available
   
   

   
   Biomed Rep

7. HE W, Luo T, Qin C, Liu X, et al
   Clinical efficacy and outcomes of enhanced recovery after surgery for laparoscopic cervical cancer.
   Biomed Rep. 2026;25:120.
   PubMed         Abstract available
   
   

   
   Biosci Rep

8. LI N, Zhang W
   Expression of Concern: Protein kinase C beta inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatin.
   Biosci Rep. 2026;46:BSR20160445.
   PubMed        
   
   

   
   BMC Cancer

9. LEMA TF
   Epidemiology of pre-cancerous cervical lesions among women in Adama, Ethiopia.
   BMC Cancer. 2026 Jun 26. doi: 10.1186/s12885-026-16413.
   PubMed         Abstract available
   
   
10. MAI Q, Chi C, Wang X, Chen Y, et al
    Multi-omics profiling reveals sphingolipid metabolism reprogramming of tumor-conditioned MDSCs in cervical cancer.
    BMC Cancer. 2026;26:1122.
    PubMed         Abstract available
    
    

    
    BMC Med Imaging

11. MARKUS M, Sartor H, Bjurberg M, Minarik D, et al
    FDG-PET/CT-based treatment response predicts recurrence and overall survival in locally advanced cervical cancer.
    BMC Med Imaging. 2026;26:458.
    PubMed         Abstract available
    
    

    
    BMC Microbiol

12. STOSIC M, Molina MA, Mukhedkar D, Hassan SS, et al
    Inferred functional microbiome features are associated with clinical trajectories of low-grade cervical lesions.
    BMC Microbiol. 2026;26:802.
    PubMed         Abstract available
    
    

    
    BMC Pregnancy Childbirth

13. SHENG YR, Xiao XR, Ye YZ
    Full-term delivery in pregnancy complicated with suspected residual cervical alveolar soft part sarcoma: a case report and literature review.
    BMC Pregnancy Childbirth. 2026;26:1029.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

14. EVARIST MR, Kibonire RA
    Bridging the service gap: health facility challenges in HPV vaccine uptake in rural Uganda.
    BMC Womens Health. 2026;26:456.
    PubMed         Abstract available
    
    
15. WANG K, Lin L, Lin H, Chen Z, et al
    Correlation analysis of bacterial vaginosis with HPV infection and different grades of cervical lesions.
    BMC Womens Health. 2026;26:453.
    PubMed         Abstract available
    
    

    
    BMJ Open

16. DOTO D, Shirima LJ, Mmbaga B, Kinoko D, et al
    Adherence to follow-up cervical cancer screening and its predictors among women living with HIV in Moshi municipality, Tanzania: a hospital-based retrospective cohort study (2019-2024).
    BMJ Open. 2026;16:e113748.
    PubMed         Abstract available
    
    

    
    Brief Funct Genomics

17. FU A, Cai J, Chen R, Zou X, et al
    AGRN activates GPX4 via the Wnt/beta-catenin signaling pathway to suppress ferroptosis in cervical cancer cells.
    Brief Funct Genomics. 2026;25:elag010.
    PubMed         Abstract available
    
    

    
    Can Oncol Nurs J

18. AMADI AI, Lawal M, Khan HTA, Japhet SL, et al
    Examining women's perspectives regarding colposcopy in the cervical cancer screening program in rural Nigeria.
    Can Oncol Nurs J. 2026;36:262-271.
    PubMed         Abstract available
    
    

    
    Cancer Treat Res Commun

19. XIE M, Li Q
    Tissue factor-targeted antibody-drug conjugates in cervical cancer: Focus on tisotumab vedotin.
    Cancer Treat Res Commun. 2026;49:101400.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

20. MUANGWONG P, Tharavichitkul E, Chakrabandhu S, Klunklin P, et al
    Clinical Outcomes and Prognostic Factors Following Routine CT-Based Image-Guided Adaptive Brachytherapy for Cervical Cancer: A Retrospective Cohort Study.
    Cancers (Basel). 2026;18:2805.
    PubMed         Abstract available
    
    
21. KAHESA C, Gonzalez D, Samwel K, Loy D, et al
    Adequacy of Visual Inspection with Acetic Acid (VIA) in Comparison to Pap Smear for Cervical Cancer Screening in Urban and Rural Settings of Tanzania.
    Cancers (Basel). 2026;18:2811.
    PubMed         Abstract available
    
    
22. LEE HJ, Lee B
    Impact of Post-Primary Treatment Hormone Replacement Therapy on Survival in Women with Cervical Cancer.
    Cancers (Basel). 2026;18:2841.
    PubMed         Abstract available
    
    
23. STANIC J, Popovic-Vukovic M, Nikic P, Sovic I, et al
    Evolving Clinicopathological Characteristics of Women with Locally Advanced Cervical Cancer Treated with Definitive Chemoradiation Before and After Implementation of Organized Cervical Cancer Screening in Serbia.
    Cancers (Basel). 2026;18:2891.
    PubMed         Abstract available
    
    

    
    China CDC Wkly

24. WANG C, Li P, Wang J
    Research Progress on Biomarkers Associated with Cervical Cancer Caused by HPV Infection.
    China CDC Wkly. 2026;8:1075-1083.
    PubMed         Abstract available
    
    

    
    Diagnostics (Basel)

25. KIM CY, Lee SW, Chong GO, Kim JM, et al
    Diagnostic Performance of Post-Treatment F-18 FDG PET/CT for Detecting Recurrent Cervical Cancer.
    Diagnostics (Basel). 2026;16:2691.
    PubMed         Abstract available
    
    
26. CIUHODARU M, Calin AM, Nitu BF, Cambrea CS, et al
    Veil-Based Collector Device Enabling Self-Collected Cervicovaginal Sampling for Site-of-Care Primary HPV-Based Cervical Cancer and Sexually Transmitted Infections Screening: A Pilot Feasibility Study in Romania.
    Diagnostics (Basel). 2026;16:2765.
    PubMed         Abstract available
    
    

    
    Eur Radiol

27. YANG W
    Reply to the Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection.
    Eur Radiol. 2026 Sep 18. doi: 10.1007/s00330-026-12898.
    PubMed        
    
    
28. JIA J, Wang L, Wang F
    Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection.
    Eur Radiol. 2026 Sep 18. doi: 10.1007/s00330-026-12897.
    PubMed        
    
    

    
    F1000Res

29. ADEJIMI AA, Dawodu O, Soibi-Harry AP, Alabi A, et al
    Gaps in Knowledge and Practice of Cervical Cancer Screening among Primary Health Care Workers in Lagos State, Nigeria: A Cross-Sectional Study.
    F1000Res. 2026;15:629.
    PubMed         Abstract available
    
    

    
    Front Genet

30. FAN X, Chen L, Xu J, Zheng S, et al
    Lymphangiogenesis-related gene signature-based risk model for prognostic assessment of cervical cancer: immune-metabolic characterization and molecular subtype analysis.
    Front Genet. 2026;17:1835653.
    PubMed         Abstract available
    
    

    
    Front Immunol

31. YANG C, Song X, Sun H, Chen M, et al
    Immune remodeling during cervical cancer chemoradiotherapy: temporal biomarkers and the timing of checkpoint blockade.
    Front Immunol. 2026;17:1947595.
    PubMed         Abstract available
    
    

    
    Front Oncol

32. LI X, Qiu J, Lin T, Ye Y, et al
    Prognostic significance of pretreatment peripheral blood inflammatory biomarkers in elderly patients with locally advanced cervical cancer undergoing definitive chemoradiotherapy.
    Front Oncol. 2026;16:1935344.
    PubMed         Abstract available
    
    
33. LIN B, Huang X, Huang H, Xie K, et al
    An investigational prognostic framework for stage IVB cervical cancer based on metastatic patterns: a population-based study with exploratory external evaluation.
    Front Oncol. 2026;16:1931638.
    PubMed         Abstract available
    
    
34. LI F, Tian X, Mei F, Du Y, et al
    The expression and clinical significance of SIRT5, H2A and TOP2A in cervical cancer.
    Front Oncol. 2026;16:1899320.
    PubMed         Abstract available
    
    
35. IRAKIZA PM, Gashaija A, Muhammed S, Rubuga FK, et al
    Leveraging machine learning algorithms to assess the impact of cervical cancer early detection on patients' survival.
    Front Oncol. 2026;16:1880629.
    PubMed         Abstract available
    
    
36. WU X, Xu C, Shi S, Ye C, et al
    An interpretable MRI radiomics approach for preoperative prediction of lymphovascular space invasion in cervical cancer using optimal peritumoral region.
    Front Oncol. 2026;16:1859587.
    PubMed         Abstract available
    
    

    
    Front Public Health

37. UMBETZHANOVA A, Kusniyeva A, Derbissalina G, Aigul A, et al
    Digital tools to enhance adherence to cervical cancer prevention practices: systematic review.
    Front Public Health. 2026;14:1851751.
    PubMed         Abstract available
    
    

    
    Genomics Proteomics Bioinformatics

38. REN P, Wen L, Zhang Z, Wu M, et al
    Hypoxia Response Is Associated with Reduced HPV Activity and Tumor Microenvironment Remodeling in Cervical Cancer.
    Genomics Proteomics Bioinformatics. 2026.
    PubMed         Abstract available
    
    

    
    Healthcare (Basel)

39. MAGHIAR L, Paiusan F, Chioibas R, Neamtu AA, et al
    Cervical Cancer Screening Activity at an Accredited Centre in Romania, 2018-2025: COVID-19 Disruption, Recovery and the Transition to Primary HPV Testing.
    Healthcare (Basel). 2026;14:2850.
    PubMed         Abstract available
    
    
40. MAHMOUD NSA, Hendawi NE, Khedr MA, Almegewly WH, et al
    Effect of Mindfulness-Based Social-Emotional Learning Approach on Knowledge and Anxiety Levels Regarding Cervical Cancer Prevention.
    Healthcare (Basel). 2026;14:2684.
    PubMed         Abstract available
    
    

    
    Int J Clin Oncol

41. TAKAHASHI Y, Takei Y, Takadera M, Taguchi M, et al
    Clinical activity of platinum rechallenge with nedaplatin plus irinotecan in recurrent cervical cancer following prior platinum-based systemic chemotherapy: a single-center retrospective study.
    Int J Clin Oncol. 2026 Sep 17. doi: 10.1007/s10147-026-03196.
    PubMed         Abstract available
    
    

    
    Int J Hematol Oncol Stem Cell Res

42. DAS K, Suryarao P
    Opportunistic Cervical Cancer Screening Using Liquid-Based Cytology in a Gynaecology Outpatient Setting: A Cross-Sectional Study.
    Int J Hematol Oncol Stem Cell Res. 2026;20:144-151.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

43. BOU ANTOUN N, Afshan Mahmood HT, Walker AJ, Modjtahedi H, et al
    Correction: Bou Antoun et al. Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research. Int. J. Mol. Sci. 2025, 26, 1799.
    Int J Mol Sci. 2026;27:7598.
    PubMed         Abstract available
    
    
44. HE J, Sun Y, Yang Z, Xu D, et al
    Comprehensive Analysis of Cuproptosis-Related Genes According to Cancer Stage and Their Prognostic Value in Cervical Cancer.
    Int J Mol Sci. 2026;27:7730.
    PubMed         Abstract available
    
    

    
    J Adv Nurs

45. KYEI GK, Kyei EK, Ansong R
    Achieving Cancer Prevention Equity: A Policy Analysis of American Cancer Society HPV Vaccination Guidelines.
    J Adv Nurs. 2026;82:9384-9398.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Res

46. ZHANG X, Zhu T, Gao Z, Han Z, et al
    Cervical, Uterine, and Ovarian Cancers in Chinese Women Aged 55 Years and Older: Burden, Temporal Trends, Risk Attribution, and Future Projections From the Global Burden of Disease Study 2021.
    J Obstet Gynaecol Res. 2026;52:e70413.
    PubMed         Abstract available
    
    

    
    J Photochem Photobiol B

47. CAROBELI LR, de Freitas Meirelles LE, da Silva LMBP, Dos Santos JJ, et al
    Synergistic effects of hypericin-mediated photodynamic therapy and low-dose cisplatin on cervical cancer cells.
    J Photochem Photobiol B. 2026;284:113566.
    PubMed         Abstract available
    
    

    
    JCO Glob Oncol

48. RUBAGUMYA F, Kwizera V, Mutetiwabo I, Adedemeji A, et al
    Decentralizing Post-Treatment Follow-Up for Cervical Cancer in Rwanda: Perspectives of Survivors and Clinicians.
    JCO Glob Oncol. 2026;12:e2600131.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

49. ZHENG P, Chen W, Jiang M
    Psychiatric disorders and gynecologic tumors: A 2-sample Mendelian randomization study of 20 exposure-outcome pairs.
    Medicine (Baltimore). 2026;105:e50669.
    PubMed         Abstract available
    
    
50. QI L, Wu Y, Luo M
    Meta-analysis of PAX1/JAM3 methylation performance in high-risk HPV-positive women.
    Medicine (Baltimore). 2026;105:e50757.
    PubMed         Abstract available
    
    
51. JIN H, Piao Z, Wen W
    Successful treatment of massive stage IIIB cervical cancer with a spindle cell component: A case report.
    Medicine (Baltimore). 2026;105:e50727.
    PubMed         Abstract available
    
    

    
    Nat Biomed Eng

52. XIU X, Wu Y, Li J, Lin D, et al
    Anchored random reverse primer sequencing for quantitative detection of novel gene fusions.
    Nat Biomed Eng. 2026;10:1855-1870.
    PubMed         Abstract available
    
    

    
    Naunyn Schmiedebergs Arch Pharmacol

53. TRIPATHI T, Kumar S, Joshi U, Chaudhary A, et al
    Psoralidin inhibits stemness-associated characteristics in cervical cancer cells via modulation of Oct4/Sox2 expression.
    Naunyn Schmiedebergs Arch Pharmacol. 2026.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol Int

54. TOUNKARA FK, Sissoko A, Traore M, Diawara B, et al
    Cervical Cancer Survival in Mali: A 21-Year Retrospective Cohort Study of Trends, Determinants, and Outcomes at Gabriel Toure Teaching Hospital (2003-2024).
    Obstet Gynecol Int. 2026;2026:9966827.
    PubMed         Abstract available
    
    

    
    Perm J

55. BASMAJIAN K, Thai D, Gajanayake H, Khan Z, et al
    Metastatic Breast Cancer to the Cervix and Endometrium Mimicking a Primary Gynecologic Malignancy.
    Perm J. 2026;30:190-194.
    PubMed         Abstract available
    
    

    
    PLOS Glob Public Health

56. BULAMBA RM, Nalugoda F, Miller AP, Daama A, et al
    "Even with one Man, but with many women, you can get cervical cancer": Qualitative exploration of women's perceptions and experiences of cervical cancer screening in Uganda: A community-based study.
    PLOS Glob Public Health. 2026;6:e0007256.
    PubMed         Abstract available
    
    

    
    Public Health

57. ESTEIRE I, Reina G, Royo M, Chiva L, et al
    Cervical cancer screening in Sub-Saharan Africa: A scoping review of test and treat and test, triage and treat approaches.
    Public Health. 2026;259:106445.
    PubMed         Abstract available
    
    

    
    Semin Ultrasound CT MR

58. DAYANI D, Ramani N, Hage MAC, Virarkar M, et al
    Neuroendocrine Carcinoma of Cervix: Comprehensive Review of Epidemiology, Pathology, and Advanced Imaging Modalities.
    Semin Ultrasound CT MR. 2026;47:360-373.
    PubMed         Abstract available
    
    

    
    Spectrochim Acta A Mol Biomol Spectrosc

59. LI N, Yan W, Wang Z, Ren H, et al
    Targeting mitochondrial G-quadruplex DNA with a theragnostic small molecule for cervical Cancer imaging and therapy.
    Spectrochim Acta A Mol Biomol Spectrosc. 2026;365:128793.
    PubMed         Abstract available
    
    

    
    Wiad Lek

60. PONZEL N, Kolesnik P
    Validation of Ukrainian breast and cervical cancer screening questionnaire.
    Wiad Lek. 2026;79:1581-1590.
    PubMed         Abstract available
    
    

    
    Zhonghua Yu Fang Yi Xue Za Zhi

61. YUAN XH, Chen Y, Kuang ZY, Fang LY, et al
    [Analysis of the global disease burden of cervical cancer in women aged 65 years and older based on the global burden of disease database].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2026;60:1436-1446.
    PubMed         Abstract available
    
    
62. YANG YJ, Zhu YT, Qiu WQ, Ding HY, et al
    [Exploration of a cervical cancer prevention and treatment model in low-resource regions supported by emerging technologies].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2026;60:1555-1560.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum